Blog
RSS FeedPosted by Michael Wonder on 03 Sep 2025
'More than my rent': NSW woman's $1000 a month fight for relief
3 September 2025 - Six years ago, Raphaella Kathryn Crosby could barely get out of bed. ...
Posted by Michael Wonder on 03 Sep 2025
Health Canada approves Elahere for certain types of platinum-resistant ovarian cancers
2 September 2025 - Elahere received approval through Health Canada's priority review process, based on data from the pivotal MIRASOL Phase ...
Posted by Michael Wonder on 02 Sep 2025
DoH publishes revised agenda for September 2025 PBAC meeting (version 2)
2 September 2025 - The agenda for the September 2025 PBAC meeting has now been updated. ...
Posted by Michael Wonder on 02 Sep 2025
Multiple myeloma drug Darzalex to get expanded coverage from September
29 August 2025 - Starting in September, reimbursement for the multiple myeloma treatment Darzalex (daratumumab) will be expanded, reducing the ...
Posted by Michael Wonder on 02 Sep 2025
Cost of PBS scripts to be dropped to $25 from January 1 2026
2 September 2025 - Prescriptions listed on the PBS will be cut from $31.60 to $25 from January 1, 2026, ...
Posted by Michael Wonder on 01 Sep 2025
Care for people with rare and less common cancers ‘delayed and fragmented’, new report reveals
1 September 2025 - A national survey of nearly 2,500 people affected by cancer has found those with a rare ...
Posted by Michael Wonder on 01 Sep 2025
More cheaper medicines now available for Australians
1 September 2025 - From today, Australians with paediatric psoriasis, fibrodysplasia, asthma, cystic fibrosis and blood cancer now have access ...
Posted by Michael Wonder on 01 Sep 2025
Schedule of Pharmaceutical Benefits - 1 September 2025
1 September 2025 - The September 2025 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 01 Sep 2025
New Zealand Pharmaceutical Schedule - 1 September 2025
1 September 2025 - The September 2025 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 31 Aug 2025
FDA approval of Leqembi subcutaneous formulation charts path to combination therapies for Alzheimer's disease
29 August 2025 - Subcutaneous delivery increases accessibility and introduces potential for at home administration, following model of diabetes and ...
Posted by Michael Wonder on 31 Aug 2025
Game changing asthma treatment for kids listed on PBS
29 August 2025 - A new antibody treatment for severe asthma in children is about to become significantly more affordable ...
Posted by Michael Wonder on 31 Aug 2025
Sanofi’s Wayrilz approved in US as first BTK inhibitor for immune thrombocytopenia
29 August 2025 - Approval based on LUNA 3 Phase 3 study that demonstrated rapid and durable platelet response and improvements ...
Posted by Michael Wonder on 31 Aug 2025
Vabysmo (faricimab injection) now publicly funded for macular oedema secondary to retinal vein occlusion in Ontario
29 August 2025 - Roche Canada is pleased to announce today that Vabysmo (faricimab injection) is now publicly funded for ...
Posted by Michael Wonder on 29 Aug 2025
UK Government, pharma industry fail to agree on medicines payment scheme
28 August 2025 - Negotiations between the UK Government and the pharmaceutical industry have ended without an agreement on changes ...
Posted by Michael Wonder on 29 Aug 2025
Public Summary Documents – May 2025 PBAC meeting
29 August 2025 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the May 2025 PBAC ...